Li T - Search Results

1

[Neoadjuvant treatment in human epidermal growth factor receptor 2-positive breast cancer].

Liu Y, Liu S, Zhang H, Xu L, Li T, Duan X. Liu Y, et al. Among authors: li t. Zhonghua Wai Ke Za Zhi. 2015 Dec 1;53(12):901-4. Zhonghua Wai Ke Za Zhi. 2015. PMID: 26850663 Chinese.

2

Clinicopathological classification and individualized treatment of breast cancer.

Hu H, Liu YH, Xu L, Zhao JX, Duan XN, Ye JM, Li T, Zhang H, Zhang S, Xiong Y. Hu H, et al. Among authors: li t. Chin Med J (Engl). 2013 Oct;126(20):3921-5. Chin Med J (Engl). 2013. PMID: 24157157

3

Multicenter prospective study of magnetic resonance imaging prior to breast-conserving surgery for breast cancer.

Liu Q, Liu Y, Xu L, Duan X, Li T, Qin N, Kang H, Jiang H, Yang D, Qu X, Jiang Z, Yu C. Liu Q, et al. Among authors: li t. Chin Med J (Engl). 2014;127(13):2401-6. Chin Med J (Engl). 2014. PMID: 24985573

4

[Role of magnetic resonance imaging for response evaluation and predictive value of tumor biomarkers in the neoadjuvant chemotherapy for breast cancer:a multi-center prospective study].

Xin L, Liu Q, Xu L, Jiang Z, Jiang H, Qin N, Li T, Duan X, Liu Y. Xin L, et al. Among authors: li t. Zhonghua Yi Xue Za Zhi. 2014 Jul 8;94(26):2018-21. Zhonghua Yi Xue Za Zhi. 2014. PMID: 25312661 Chinese.

5

Intratumoral heterogeneity of HER2 gene amplification in occult breast cancer.

Xin L, Zhang H, Zhang S, Ye J, Li T, Liu Y. Xin L, et al. Among authors: li t. Chin Med J (Engl). 2014;127(20):3676-7. Chin Med J (Engl). 2014. PMID: 25316250 No abstract available.

6

[Evaluation and indication of human epithelial growth factor receptor 2 status in breast carcinoma with amplified chromosome].

Zhang S, Wang Y, Guo ZM, Zhang H, Xu L, Liu YH, Li T. Zhang S, et al. Among authors: li t. Beijing Da Xue Xue Bao Yi Xue Ban. 2014 Oct 18;46(5):686-90. Beijing Da Xue Xue Bao Yi Xue Ban. 2014. PMID: 25331387 Free article. Chinese.

7

[Analysis of detecting value of ultrasound and the clinic-pathological features of axillary metastasis in breast cancer].

Xin L, Chen L, Zhang H, Liu Q, Xu L, Wang B, Li T, Duan X, Liu Y. Xin L, et al. Among authors: li t. Zhonghua Wai Ke Za Zhi. 2014 Dec;52(12):924-8. Zhonghua Wai Ke Za Zhi. 2014. PMID: 25622584 Chinese.

8

[Re-evaluation of HER2 status in 1 501 invasive breast cancers according to the 2013 American Society of Clinical Oncology/College of American Pathology guidelines].

Zhang H, Zhang S, Wang Y, Li D, Xu L, Liu Q, Duan X, Liu Y, Li T. Zhang H, et al. Among authors: li d, li t. Zhonghua Bing Li Xue Za Zhi. 2015 Jan;44(1):42-7. Zhonghua Bing Li Xue Za Zhi. 2015. PMID: 25765030 Chinese.

9

Optimal threshold for stromal tumor-infiltrating lymphocytes: its predictive and prognostic value in HER2-positive breast cancer treated with trastuzumab-based neoadjuvant chemotherapy.

Liu S, Duan X, Xu L, Xin L, Cheng Y, Liu Q, Ye J, Zhang S, Zhang H, Zhu S, Li T, Liu Y. Liu S, et al. Among authors: li t. Breast Cancer Res Treat. 2015 Nov;154(2):239-49. doi: 10.1007/s10549-015-3617-7. Epub 2015 Oct 26. Breast Cancer Res Treat. 2015. PMID: 26498019

10

Nuclear Gli1 expression is associated with pathological complete response and event-free survival in HER2-positive breast cancer treated with trastuzumab-based neoadjuvant therapy.

Liu S, Duan X, Xu L, Ye J, Cheng Y, Liu Q, Zhang H, Zhang S, Zhu S, Li T, Liu Y. Liu S, et al. Among authors: li t. Tumour Biol. 2016 Apr;37(4):4873-81. doi: 10.1007/s13277-015-4325-y. Epub 2015 Nov 2. Tumour Biol. 2016. PMID: 26526577

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

39,874 results

Search Page

Filters